Background: Reduced engagement with habitual activity (HA) is associated with greater risk and progression of cognitive decline and falls in older adults and people with dementia. Understanding external and intrinsic factors that affect HA may provide novel targets for non-pharmacologic interventions. Objective: This study primarily aims to identify factors that influence HA in normal ageing and cognitive impairment, such as cognitive and motor problems and disease subtype. Methods: 108 older adults participated in this study; 36 with cognitive impairment due to Alzheimer's disease (AD), 30 with dementia with Lewy bodies (DLB), 16 with Parkinson's disease dementia (PDD), and 26 controls. A triaxial accelerometer recorded continuous data of volume, variability, and pattern of HA over 7 days. Participants undertook a battery of cognitive and neuropsychological assessments. Results: One-way analysis of variance controlling for age and gender shows that people with DLB and PDD engage less with HA than controls (p ≤ 0.01), but there were no significant differences between AD and controls (p ≥ 0.01).
Introduction
Lower levels of every-day (habitual) activities (HA) are associated with worse cognitive function [3] and well-being [4] . Therefore, it may be important to quantify HA and target factors which influence HA when managing cognitive disorders, such as motor problems, history of falls, and lack of balance confidence.
Quantification of habitual behaviours using wearable technologies provides a truer picture of a person's overall daily activity (e.g., steps per day and sum of activity DOI: 10.1159/000502288 counts) compared to self-report measures, and has been related to global cognitive performance [5] , development of Alzheimer's disease (AD), and rate of global cognitive decline [6] . It is unclear if the presence of dementia reduces daily activity, or if reduced daily activity contributes to cognitive decline [7] . Therefore, a better understanding of the role cognition plays in facilitating daily activity in people with cognitive impairment is required.
However, total daily activity is a broad measure. Considering discrete characteristics relating to the volume, pattern, and variability in HA allows a more nuanced approach to understand these data [8] . Volume refers to amount of activity such as total walking time or number of steps taken, while the pattern describes length of walking bouts and the relative distribution of walking bout lengths, and variability measures the variability of bout lengths. This framework of HA allows us to understand the amount and type of activity individuals engage with, providing a novel insight into how cognitive impairment may affect a person's daily life. For example, differences in variability and pattern of walking may indicate less engagement with different types of HA, and shorter bouts may reflect a more constrained environment and less time spent outside the home [9] . These novel HA characteristics have applications in the identification of frailty in older adults [10] and for the incidence and risk of falls in different neurodegenerative disorders [11, 12] . By moving beyond simply measuring total daily activity, we can provide a detailed picture of a person's functional abilities and day-to-day activity [8, 12, [14] [15] [16] .
The majority of research into HA in dementia has simply considered volume of activity in people with cognitive impairment irrespective of disease subtype [17] [18] [19] [20] [21] . As of yet, factors which encourage or limit volume, variability, and pattern of HA in cognitive impairment have not been identified, nor have these novel metrics been described in overarching cognitively impaired group or compared between different dementia disease subtypes, such as AD, dementia with Lewy bodies (DLB), and Parkinson's disease dementia (PDD). Disease-specific differences in HA may be an important consideration for disease management and care as it may inform which disease subtypes have the greatest need for early interventions.
Therefore, this study aims to move beyond the current research and to describe differences in volume, pattern, and variability of HA between people with cognitive impairment regardless of underlying cause and cognitively intact controls, identify factors that influence HA engagement, and consider the impact of dementia disease subtype on HA by comparing subgroups of AD, DLB, and PDD. We hypothesize that (1) people with cognitive im-pairment in any disease subtype will engage less in HA than controls and (2) that this will be most prominent in people with DLB and PDD as they have concurrent motor problems. We also hypothesized that (3) volume of HA would be explained by lack of balance confidence and motor disease burden, while (4) HA pattern and variability will be explained by impaired cognitive functions.
Materials and Methods

Study Participants
Participants (n = 125) with probable mild cognitive impairment (MCI) and probable dementia due to AD, DLB, and PDD, as well as controls were recruited. Two independent clinicians reviewed participants' medical notes and assessments in order to verify disease diagnosis. A third clinician reviewed disagreements, providing a consensus for diagnosis. Relevant diagnostic criteria for AD, DLB, and PDD [22] [23] [24] , and MCI [25, 26] were used; MCIs due to AD and Lewy body disease (were identified as described in Donaghy et al. [27] , Thomas et al. [28] , and King et al. [29] . Control participants of a similar age were recruited to account for effects of ageing on habitual walking behaviours.
All participants had to be over 60 years old, have capacity to consent, and able to walk for 2 min, as ascertained by self-report. Participants were excluded if they had drug-induced or vascular parkinsonism, any co-existing neurological conditions or movement disorders, severe mental illness (major depression, bipolar disorder, or schizophrenia), evidence of stroke affecting motor function, or poor command of the English language. Controls must be cognitively intact (Mini Mental State Examination [MMSE] ≥0.25), functionally independent, no diagnosis of dementia, no diagnosis of Parkinson's disease, and not on any medication to treat dementia or Parkinson's disease.
Clinical Assessment
Age, gender, height, and weight were recorded. All participants reported any falls in the last 12 months. The National Adult Reading Test (NART) [30] , Cumulative Illness Rating Scale-Geriatrics (CIRS-G) [31] , Movement Disorders Society Unified Parkinson's Disease Rating Scale part III (UPDRS-III) [32] , Clinical Dementia Rating Scale (CDR) [33] , Activities Balance Confidence Scale (ABC) [34] , Epworth Sleepiness Scale (ESS) [35] , Geriatric Depression Scale (GDS) [36] , and Bristol Activities of Daily Living Scale (BADLS) were also assessed [37] .
Cognitive Assessment
Global cognition was measured using the standardised MMSE [38] and Addenbrookes Cognitive Examination III (ACE-III) [39] . The ACE-III subscales measured attention, memory, language, fluency, and visuospatial function. The Trail Making Task A (TMT-A) measured information processing speed [40] . The F-A-S Verbal Fluency Test measured verbal fluency and executive function [41] . The simple reaction time computerised test measured attention.
Measurement of Habitual Activity
Participants were asked to wear a body-worn monitor (Axivity AX3, York, UK; dimensions 23.0 × 32.5 × 7.6 mm; weight: 11 g; Gerontology 2020;66:197-208 DOI: 10.1159/000502288 accuracy 20 parts per million) on their lower backs continuously for 7 days. Data from the body-worn monitors were downloaded to a computer and segmented by day. Analysis was carried out using a MATLAB programme. The full process from initial placement of the body-worn sensor through to data extraction and output is depicted in Figure 1 . A framework of outcomes including volume, pattern, and variability in walking activity was derived to aid data interpretation [8] and is described below:
Accelerometer signals were transformed to a horizontal-vertical coordinate system and filtered with a 4th-order Butterworth filter at 20 Hz.
For each day, walking bouts were identified by applying selective thresholds on the vector magnitude and the standard deviation of tri-axial acceleration signals [further detailed in 42] . A bout is defined as any continuous period of walking. In order to enhance robustness and remain consistent with previously published findings [14, 16] , a minimum bout length of 3 consecutive steps was applied, and there was no resting time threshold -if an individual stopped walking, their next 3 steps would be considered a new bout.
The Gaussian continuous wavelet transform of vertical acceleration was applied to smooth the data and filter out potential errors [42] . Initial contact (heel strike) and final contact (toe-off) events of the gait cycle were identified, representing a step. Total steps per bout and bout length could be calculated for each bout. The total number of bouts was calculated through bout identification.
Volume
Volume characteristics included total walk time, total steps, and total bouts (individual period of walking) per day and were calculated by gathering information across all identified bouts. These were divided by the number of days collected to provide average values per day.
Pattern
Characteristics of walking patterns included mean length of walking bouts and α. α is derived by logarithmic transformation of bout density and length, and is based on shape and power-law distribution [44, 45] . α refers to the distribution of bouts, describing the ratio of short to long walking bouts which are scaled relative to an individual's shortest walking bout. For example, a high α score means total walking time is made up of proportionally shorter walking bouts compared to long walking bouts.
Variability (S 2 )
Variability (S 2 ) refers to variability of bout length between walking bouts and was estimated using maximum likelihood technique (previously described Del Din et al. [9] and Mc Ardle, et al. [14] ). This describes how widespread the data are, providing an estimation of how much an individual's bout length changed across the time period. Low variability may occur when a person engages in a low repertoire of activities, while high variability may indicate a person is engaging in a wide range of activities -driving a high variability of bout length [12, 43] .
Data Analysis
Data were assessed for normality by inspection of histograms and boxplots and the Shapiro-Wilk test. χ 2 tests were used to determine differences between groups for gender and faller status (participants with and without falls during the previous year).
One-way analysis of variance (ANOVA) and Kruskal-Wallis tests were used to examine differences between groups (p ≤ 0.05) for all demographic, cognitive, and clinical variables; Fisher's least significant difference post hoc and Mann Whitney U tests established where differences lay between groups in order to assess their comparability.
First, stepwise analysis of covariance (ANCOVA) assessed differences between controls and the overall cognitively impaired [14] . Example of a body-worn monitor centrally located on the lower back (L5) for free-living data collection (a) and protocol for home-based assessments (b). The raw vertical acceleration signal segmented into walking bouts (c). Left: identification of walking bouts (red bars) from free-living data from which habitual activity characteristics are extracted (d). e Macro characteristics of gait described by domains of volume, pattern, and variability. DOI: 10.1159/000502288 group for HA while controlling for age and gender. A more stringent statistical threshold of p ≤ 0.01 was applied to account for multiple comparisons. Effect sizes (partial η 2 ) were calculated for key significant differences between groups. Effect sizes were interpreted according to guidelines [46] : small (0.01-0.06), medium (0.06-0.14), and large (> 0.14). Following this, the relationships between HA and outcomes representing personal, cognitive, motor, and mood characteristics were explored separately in controls and the cognitively impaired group using univariate regression. Only univariate regressions were considered in the control group due to the small sample size; however, significant explanatory variables were further explored in the cognitively impaired group through multivariate backward stepwise regression. Statistical significance was considered to be p ≤ 0.05.
Finally, stepwise ANCOVA assessed differences in HA between people with AD, DLB, and PDD and controls (p ≤ 0.01) to address the impact of dementia disease subtype on HA engagement. Effect sizes (η 2 ) were calculated between groups for significant differences. Associations between personal, cognitive, and motor outcomes with HA were examined in each dementia disease subtype using Spearman ρ correlations in order to further explore disease-specific influences on HA.
Results
Demographics
Seventeen patients were excluded from this analysis due to withdrawal from the study (n = 2), clinical diagnosis other than AD and DLB (n = 11), problems with data upload (n = 2), monitor lost in the post (n = 1), and refusal to wear the sensor (n = 1). This left 108 participants: 82 with cognitive impairment (36 AD, 30 DLB, and 16 PDD) and 26 controls. Five participants collected < 7 days data due to hospitalisation (n = 1), discomfort (n = 1), and quality checks (n = 3). Participants were still included as data are reported as measures per day, and all participants had > 3 days data collected; data collection for 3-7 days is the current standard of free-living gait analysis [47] .
Participants in the disease groups ranged from MCI to moderate dementia, but groups were primarily composed of mild dementia cases (see Table 1 for all clinical and demographic information). There were no significant differences for any macro gait characteristics between the MCI and dementia groups within each subtype; therefore, it was deemed feasible to include both disease stages in each group (see online suppl. Table 1 ; see www.karger.com/ doi/10.1186/000502288 for all online suppl. material).
HA Differences in Cognitive Impairment and Normal Ageing
Volume. People with cognitive impairment spent significantly less time walking and took less steps per day compared to controls ( Table 2) .
Pattern. People with cognitive impairment took significantly shorter walking bouts than controls. The distribution of their walking bouts demonstrated trends towards a greater proportion of short than long walking bouts (higher α score).
Variability. People with cognitive impairment demonstrated less variability for bout lengths compared to controls.
Factors That Influence HA in Normal Ageing and Cognitive Impairment
The significant univariate associations between HA characteristics and possible contributing factors (e.g., demographics, motor disease, cognition, balance confidence, and impairments in activities of daily living, ADL) are summarised in Table 3 for the control group and Table 4 for the cognitively impaired group. All univariate regressions are reported in online supplementary Table 2 for the control group and in online supplementary Table  3 for the cognitively impaired group.
Volume
In the cognitively impaired group, all volume characteristics were explained by greater motor disease severity and greater ADL impairments, explaining 26.1% of the variance in time spent walking; 20.8% of the variance for steps taken, and 17.1% of the variance for bouts taken per day (Table 4 ). Motor disease severity demonstrated moderate-strong negative associations with time spent walking, steps, and bouts per day in all disease subtypes (see online supplementary Tables 4-6 ). Volume of HA (walk time per day, steps per day, and bouts per day) was not significantly explained by any of the considered factors in the control group.
Pattern
In the cognitively impaired group, shorter bout lengths were greater motor disease severity, accounting for 9% of the variance (Table 4 ). Higher α scores were explained by greater motor disease severity, and greater verbal fluency impairment demonstrated similar trends -this model explained 8.9% of the variance.
Shorter bout length was explained by greater attentional impairment (13.9% of variance) and being female (26.5% of variance; Table 3 ), while higher α scores were explained by being female (19.1% of variance) and older age (16.2% of variance) in controls.
Variability
In the cognitively impaired group, greater variability in bout length was explained by the incidence of a fall within the previous year and greater balance confidence, accounting for 12.5% of the variance (Table 4 ).
In the control group, less variability of bout length was explained by being female (22.5% of variance), greater attentional impairment (17.3% of variance), and slower information processing (11.6% of variance; Table 3 ).
Impact of Disease Subtype on HA in People with
Cognitive Impairment Volume. People with DLB (p = 0.003; η 2 = 0.161) and PDD walked significantly less (p = 0.002; η 2 = 0.239) and took less steps per day (DLB: p = 0.002, η 2 = 0.178; PDD: p = 0.002, η 2 = 0.241) compared to controls. There were no significant differences between any groups for number of bouts taken per day (p ≥ 0.01), or between AD and controls or DLB for any characteristics (p ≥ 0.01).
Pattern. The PDD group had a higher α score compared to controls (p ≤ 0.001, η 2 = 0.356), AD (p ≤ 0.001, η 2 = 0.307), and DLB (p = 0.009, η 2 = 0.156) ( Table 2 ; Fig. 2 ) and took shorter walking bouts (p = 0.003, η 2 = 0.174) compared to the AD group. People with DLB (p ≤ 0.001, η 2 = 0.287) and PDD (p ≤ 0.001, η 2 = 0.366) also took shorter walking bouts compared to controls. There were no significant differences between AD and controls or DLB (p ≥ 0.01).
Variability. People with PDD (p ≤ 0.001, η 2 = 0.366) and DLB (p ≤ 0.001, η 2 = 0.188) were less variable in their walking bout lengths compared to controls. People with PDD were also less variable (p ≤ 0.001, η 2 = 0.206) compared to the AD group. There were no significant differences between AD and controls or DLB (p ≥ 0.01).
Discussion
The aim of this study was to compare HA between normal ageing and cognitive impairment, consider factors that influence HA, and explore the impact of dementia disease subtype on HA. Key findings suggest that people with cognitive impairment have lower volume, impaired patterns, and less variability in HA compared to normal ageing, and this appears most prominent in people with DLB and PDD. The factors which influenced HA differed between cognitively intact and cognitively impaired older adults.
Factors That Influence Habitual Activity in Normal Ageing
This study provided a novel overview of the differences in HA between cognitively intact older adults and people with cognitive impairment as it goes beyond simply reporting of step counts and overall activity [48] . Fitting with hypothesis 1, cognitively intact older adults have a greater volume and variability in HA and take proportionally more longer walking bouts compared to people with cognitive impairment. This suggests that people with cognitive impairment are less likely to engage in a variety of activities, such as housework and social calls, and may be more likely to stay within their own homes. Future research is required to provide context to these HA metrics and by doing so, allow wearable technology to provide detailed pictures of an individual's day-to-day function. This may improve our understanding of the impact of cognitive impairment on daily living and support the development of improved methods for disease management.
The influential factors of HA were different between normal ageing and cognitive impairment. In normal ageing, gender, age, and cognition played a prominent role in variability and pattern of HA. The role of gender is consistent with the previous literature, indicating that the distribution of bout lengths reflects traditional gender roles found in the older population [49] . Interestingly, gender did not contribute to HA engagement in people with cognitive impairment, which may be due to reduced ability to perform tasks traditionally associated with gender roles, and increased dependency and need for care. Future work should strive to look at this interaction in larger samples and consider the interaction between activity of the individual with cognitive impairment and their caregiver. By doing so, we may gain a unique insight into the loss of independence and evolution of caregiving in these populations.
Less variability and impaired pattern of HA was explained by subtle impairments in information processing and attention in controls. This may reflect limited abilities to engage cognitively with different kinds of activities in the home and community. This partially supports hypothesis 4, but impairments in cognitive functions did not independently contribute to the explanatory models for HA in the cognitive impairment group. Lower HA has previously been associated with greater progression and risk of cognitive decline in older adults [5, 6] , suggesting that cognitive function plays an important role in HA engagement. However, people with cognitive impairment have a multitude of other factors which influence HA, reflecting the multifactorial nature of MCI and dementia, and these may be more prominently associated with lower levels of HA once cognitive impairment is established. This study identified these potential factors as motor disease, impairments in ADL, and dementia disease subtype.
Factors That Influence HA in Cognitive Impairment
Lower volume and impaired pattern of HA in people with cognitive impairment were strongly explained by greater motor disease severity. This somewhat supports hypothesis 3 and the previous literature in PD [8] . This relationship has not only been found in the combined cognitive impairment group; associations have similarly been found in AD, DLB, and PDD when considered discretely (see online suppl. . This highlights the importance of considering motor problems in treatment protocols for MCI and dementia regardless of disease subtype. Cognitive impairment and motor problems are often considered separately in clinical practice and may therefore be neglected in individuals without visually observable motor symptoms, such as people with AD. It is also important to note that dementia disease subtypes with concurrent motor disease, such as DLB and PDD, interact less with HA compared to controls and people with AD -confirming hypothesis 2. As motor disease Gerontology 2020;66:197-208 DOI: 10.1159/000502288 may affect functional independence [50] , physical interventions and advice for HA maintenance should be implemented soon after symptoms of DLB and PDD are recognised [51] . In addition to improving functional independence, this would have added benefit to well-being, mood, and cognitive function [52] [53] [54] .
In addition to motor disease, lower volume of HA was also explained independently by greater ADL impairments, which can be considered a measure of functional independence [55] . Future research should investigate if quantifying HA could act as an objective proxy marker for assessing functional independence -reducing patient burden and reliance on self-reported subjective measures, along with allowing us to explore discrepancies between objective measurements and subjective perceptions of daily living. Tailored management of ADLs, such as providing unobtrusive aids and supervision of activities [55, 56] , may promote functional independence and increase or maintain HA; wearable technology could capture such outcomes [57] .
Limitations in Our Understanding and Interpretation of Free-Living Data
The explanatory models of HA described in this study only explain a small amount of variance, and it is important to note that there are a broad range of potential influential factors which encourage or limit HA engagement. Specific health conditions, apathy and depression, fatigue, loss of dependence, caregiver burden and health, lack of access to transportation, bad weather, and environmental constraints may all act as barriers to engaging in habitual walking activities [58] . van Alphen et al. [58] suggested that there are a range of motivators and facilitators for people with cognitive impairment to engage in activity, including dog ownership, social activities, and routine.
The large range of HA in this study (Fig. 2) highlights the impact of different limiting or encouraging factors on HA. For example, the lowest volume of HA (20 min/day) was taken by a 83-year-old woman with PDD. She preferred short walking bouts (α: 2.04) and reported only feeling safe when walking with her husband (ABC: 25/100). Her husband had taken over all household tasks traditionally delegated to her (BADLS: 13/60). The presence of motor disease, loss of independence, high levels of caregiving, and lack of confidence in walking independently may all have influenced low engagement with HA and preference for short bouts. In contrast, the highest volume of HA (373 min/day) was taken by a 78-year-old man diagnosed with MCI due to Lewy bodies. He reported being an active member of a walking club that meets regularly. He also had motor disease, but was confident in his balance (ABC: 98/100), functionally independent, and motivated to engage in social and community-based activities.
These case studies simply highlight that one size does not fit all. Individuals have a range of personal, interpersonal, environmental, cultural, and social factors that influence their engagement in behavioural activities such as walking. This must be recognised when interpreting snapshots of ambulatory activity. Free-living data are complex, personal, and highly variable. Therefore, monitoring individual trajectories of change within free-living behaviours may be more clinically useful than applying thresholds of "at-risk" behaviour [59] .
Considerations and Implications for Clinical Practice
This research has direct application towards patientcentred care. Firstly, it demonstrates that the presence of MCI or dementia is not the only reason for reduced HA. Motor disease and reduced engagement with ADLs both additionally may influence lower levels of HA and may be addressed through interventions, such as physical or occupational therapy [60] and supervision of tasks rather than direct care [56] . Additionally, future research should consider how cognition may be facilitating associations between HA, motor disease, and ADLs.
Secondly, this study has demonstrated feasibility for continuously HA monitoring in different dementia disease subtypes with wearable technology. It allows us to describe more than just volume of HA, providing a detailed insight into how cognitive impairment affects a person's daily life. There is growing interest in the health industry for the use of wearable technology for improving personalised care, and monitoring disease progression and intervention efficacy [47, [61] [62] [63] [64] [65] . In addition to providing personalised pictures of daily activity, it allows us to examine underserved areas and move beyond the need for well-controlled environments to assess models of "best practice" [64] , reducing observer bias and allowing inclusion of populations with high functional impairments. Future research should, therefore, use wearable technology to investigate factors that influence HA in different stages of cognitive impairment and in different care settings to understand how different circumstances contribute to HA engagement.
Limitations
Although this study provided novel evidence for the impact of disease subtype, cognition, functional independence, and motor disease on HA, along with the feasibility of wearable technology to provide a holistic picture of habitual behaviour, it has several limitations. As it was a single-centre study with a limited catchment area, a small but well-defined sample was recruited -multicentre studies are required to boost participant numbers. The small sample size meant we considered a spectrum of cognitive impairment to improve statistical power, and did not consider disease-specific factors that influence HA in discrete dementia disease subtypes. Larger samples are, therefore, required to understand impact of dementia severity and disease-specific effects of HA. Although the benefit of using wearable technology is their unobtrusive nature, no questionnaires were administered regarding daily activities or caregiver burden -this limited interpretation of results to that known in the literature and anecdotal evidence from participants. Finally, it is important to be cautious interpreting comparisons between older people with cognitive impairment and similarly aged controls; despite detailed cognitive testing and a consensus approach to the diagnosis and categorisation of participants in this study, individuals in "prodromal" stages of MCI and dementia are difficult to detect, and may be included in control cohorts in ageing studies.
Conclusion
In conclusion, people with cognitive impairment engage less in HA than cognitively intact older adults; however, impairments in cognitive functions are not the only influential factors of HA in people with MCI and dementia. Motor disease and impairments in ADL most strongly contribute to the lack of HA engagement; physical and occupational interventions may, therefore, be useful for facilitating HA and preserving functional independence [60] . These interventions may need to be implemented earlier in DLB and PDD compared to AD, but should still be a primary aim in clinical practice [51] . Wearable technology can provide a novel personalised method to measure HA in cognitively impaired populations, and it may be a useful objective tool for monitoring disease progression and loss of independence. Future work is required to understand how disease severity and care settings can affect engagement with HA in people with MCI and dementia.
